A new study from Bentley University's Center for Integration of Science and Industry demonstrates that the National Institutes of Health (NIH) spent $950 million on basic or applied research associated with patents that provided ...
Jul 26, 2023
0
23
Prescription drug costs represent nearly 10 percent of total health care expenses for Americans, pushing the issue to the forefront of national health care policy conversations. With rising costs an ongoing concern, a study ...
Nov 23, 2021
0
32
Adolescents who had received a mental health disorder diagnosis were often excluded from the labor market and education as young adults. This particularly applied to adolescents who had been diagnosed with an autism spectrum ...
Oct 8, 2021
0
11
The U.S. pharmaceutical industry has innovated in response to the pandemic, providing not only vaccines but also therapies to treat people with COVID-19. But an outdated law designed to spur development of lifesaving drugs ...
Jan 14, 2021
0
2
Thirty years ago, scientists began to unlock the mysteries regarding the cause of Alzheimer's disease. This knowledge ushered in an era of great enthusiasm that scientists could develop new therapies to either prevent Alzheimer's ...
Nov 16, 2017
0
58
(HealthDay)—Extending the market exclusivity for existing drugs that are granted subsequent U.S. Food and Drug Administration (FDA) approval for a new rare disease indication would provide manufacturers with substantial ...
Jan 23, 2017
0
0
High prescription drug prices are attributable to several causes, including the approach the U.S. has taken to granting government-protected monopolies to drug manufacturers, and the restriction of price negotiation at a ...
Aug 23, 2016
0
0
In a Special Communication in JAMA, "The High Cost of Prescription Drugs in the United States Origins and Prospects for Reform," Kesselheim and colleagues reviewed the peer reviewed medical and health policy literature from ...
Aug 23, 2016
0
1
Aspiring new drugs face long and stringent tests on safety and effectiveness before making it to market. And rightly so. But giving drugs special designations that bring with them the right incentives can help bring them ...
Sep 3, 2014
0
0
Canada's pharmaceutical intellectual property laws need major reform to encourage and protect innovation in developing new drugs, states an analysis in CMAJ (Canadian Medical Association Journal).
Nov 7, 2011
3
0
